127 related articles for article (PubMed ID: 15946458)
1. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass.
Lima ML; Mourão SC; Diniz MT; Leite VH
Obes Surg; 2005 May; 15(5):661-9. PubMed ID: 15946458
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.
de Almeida SR; Rocha PR; Sanches MD; Leite VH; da Silva RA; Diniz MT; Diniz Mde F; Rocha AL
Obes Surg; 2006 Mar; 16(3):270-8. PubMed ID: 16545157
[TBL] [Abstract][Full Text] [Related]
5. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
[TBL] [Abstract][Full Text] [Related]
8. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies.
Janiec DJ; Jacobson ER; Freeth A; Spaulding L; Blaszyk H
Obes Surg; 2005 Apr; 15(4):497-501. PubMed ID: 15946428
[TBL] [Abstract][Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
[TBL] [Abstract][Full Text] [Related]
10. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
11. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
12. [Obesity: risk factor for steatohepatitis and hepatic fibrosis].
Poniachik J; Mancilla C; Contreras J; Csendes A; Smok G; Cavada G; Rojas J; Oksenberg D; Burdiles P; Maluenda F; Díaz JC
Rev Med Chil; 2002 Jul; 130(7):731-6. PubMed ID: 12235896
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.
Harnois F; Msika S; Sabaté JM; Mechler C; Jouet P; Barge J; Coffin B
Obes Surg; 2006 Feb; 16(2):183-8. PubMed ID: 16469221
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
17. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.
Mottin CC; Moretto M; Padoin AV; Kupski C; Swarowsky AM; Glock L; Duval V; da Silva JB
Obes Surg; 2005; 15(6):788-93. PubMed ID: 15978148
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass.
Spaulding L; Trainer T; Janiec D
Obes Surg; 2003 Jun; 13(3):347-9. PubMed ID: 12841891
[TBL] [Abstract][Full Text] [Related]
19. The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery.
Ziolkowski A; Wylezol M; Kukla M; Zwirska-Korczala K; Berdowska A; Pardela M; Gabriel A
Obes Surg; 2005 Oct; 15(9):1309-14. PubMed ID: 16259893
[TBL] [Abstract][Full Text] [Related]
20. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
